Veenat 400 mg

Price range: $90.00 through $320.00

Veenat 400 mg Tablet, containing Imatinib mesylate, is a targeted therapy used to treat chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), and myelodysplastic syndromes (MDS). It works by inhibiting specific proteins responsible for cancer cell growth. Administered once daily with food, it offers a convenient dosing schedule. Regular monitoring through blood tests is essential to ensure safety and efficacy. Not recommended during pregnancy or breastfeeding. For more information, visit Mayo Clinic and Drugs.com.

Size
Choose an option
Veenat 400 mg
Add to cart
Buy Now
SKU: ZD-93 Category:

Veenat 400 mg Tablet contains Imatinib mesylate, a targeted therapy used to treat certain cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). By inhibiting specific proteins responsible for cancer cell growth, it helps manage these conditions effectively. For more details, see Mayo Clinic, Drugs.com, FDA, and WebMD.


Key Benefits & Uses

  • Chronic Myeloid Leukemia (CML): Targets and inhibits the abnormal BCR-ABL protein, reducing cancer cell proliferation (Healthline, PubMed).

  • Gastrointestinal Stromal Tumors (GIST): Inhibits KIT and PDGFRα receptors, slowing tumor growth (WHO).

  • Dermatofibrosarcoma Protuberans (DFSP): Effective in treating this rare skin cancer (Drugs.com).

  • Myelodysplastic Syndromes (MDS): Improves blood cell production in certain cases (Mayo Clinic).


How to Use

  • Dosage: Typically, 400 mg once daily (Mayo Clinic).

  • Administration: Take with food and a full glass of water to minimize stomach irritation (Drugs.com).

  • Alternative Method: If swallowing is difficult, dissolve the tablet in approximately 200 ml of water or apple juice, stir, and consume immediately (Drugs.com).


Important Safety Information

  • Pregnancy & Breastfeeding: Not recommended during pregnancy or breastfeeding due to potential harm to the fetus or infant (WebMD).

  • Liver/Kidney Impairment: Use with caution; dose adjustments may be necessary (FDA).

  • Drug Interactions: Avoid grapefruit juice; it may increase blood levels of Imatinib (Healthline).

  • Monitoring: Regular blood tests are recommended to monitor liver function and blood cell counts (PubMed).


Common Side Effects

  • Common: Nausea, vomiting, diarrhea, muscle cramps, fatigue, rash, and abdominal pain (WebMD).

  • Serious: Fluid retention, liver problems, and increased risk of infections (Drugs.com).


Why Choose Veenat 400 mg

  • Proven Efficacy: Demonstrated effectiveness in treating CML, GIST, and other cancers (Mayo Clinic).

  • Convenient Dosage: Once-daily administration with food (Drugs.com).

  • Established Safety Profile: Extensive clinical experience and monitoring guidelines (FDA).

Additional Information

Size

30 Tablets, 60 Tablets, 90 Tablets, 120 Tablets